Your browser doesn't support javascript.
loading
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases.
Marx, Nikolaus; Rydén, Lars; Brosius, Frank; Ceriello, Antonio; Cheung, Michael; Cosentino, Francesco; Green, Jennifer; Kellerer, Monika; Koob, Susan; Kosiborod, Mikhail; Nedungadi, Prashant; Rodbard, Helena W; Vandvik, Per Olav; Standl, Eberhard; Schnell, Oliver.
Afiliação
  • Marx N; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Rydén L; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.
  • Brosius F; University of Arizona College of Medicine, Tucson, Arizona, USA.
  • Ceriello A; IRCCS MultiMedica, Sesto San Giovanni MI, Italy.
  • Cheung M; Kidney Disease: Improving Global Outcomes, Brussels, Belgium.
  • Cosentino F; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.
  • Green J; Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Kellerer M; Marienhospital Stuttgart, Stuttgart, Germany.
  • Koob S; PCNA National Office, Madison, Wisconsin, USA.
  • Kosiborod M; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Nedungadi P; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Rodbard HW; American Heart Association, Dallas, Texas, USA.
  • Vandvik PO; Endocrine and Metabolic Consultants, Rockville, Maryland, USA.
  • Standl E; Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Schnell O; Forschergruppe Diabetes, e.V., Munich, Germany.
Diabetes Technol Ther ; 22(7): 546-552, 2020 07.
Article em En | MEDLINE | ID: mdl-32903066
ABSTRACT
The Guideline Workshop 2019, held in October 2019 in Munich, Germany, had the purpose of facilitating discussion on strategies for optimization of guideline processes in diabetes among a group of representatives of renown national and international societies in the field of diabetes, cardiology, and nephrology. Results of this panel's discussions are presented in this article and comprise a variety of suggestions for improving the quality and usability of guidelines, as well as to accelerate the development and responsiveness of guidelines to newly published, relevant data from clinical trials such as cardiovascular outcome trials in diabetes mellitus. These include, but are not limited to, recommendations to optimize presentation of content in guidelines, use of the Grading of Recommendations Assessment, Development, and Evaluation approach to rating the quality of evidence to harmonize guidelines, and utilization of digital health technologies to accelerate, streamline, and optimize communication on relevant data and development of clinical guidelines and necessary updates, while reducing costs. Recognizing that achieving alignment in guideline development among various medical organizations will be a long-term process, representatives from cross-sectional medical organizations relevant to cardio/renal metabolic disease and experts in guideline methodology will work together in the future. Among other activities, it is planned to continue the activity and organize a Guideline Workshop in 2020.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus / Nefropatias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus / Nefropatias Idioma: En Ano de publicação: 2020 Tipo de documento: Article